Neuronetics financials
$2.36−7.63%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.6M | $34.5M | $41.8M | $37.3M | $38.1M | $32.0M | $22.5M | $18.5M | $16.4M | $17.4M | $20.3M | $17.9M |
| Gross profit | $21.2M | $16.2M | $21.7M | $17.1M | $17.8M | $15.7M | $14.9M | $14.0M | $12.2M | $13.1M | $15.8M | $11.8M |
| Gross margin | 51.1% | 46.9% | 52.0% | 45.9% | 46.6% | 49.2% | 66.2% | 75.6% | 74.0% | 75.1% | 77.6% | 65.8% |
| Operating income | -$1.5M | -$9.0M | -$5.0M | -$7.3M | -$8.1M | -$11.0M | -$11.5M | -$7.7M | -$8.5M | -$6.9M | -$4.4M | -$8.9M |
| Net income | -$3.4M | -$10.8M | -$7.2M | -$9.0M | -$10.1M | -$12.7M | -$12.7M | -$13.3M | -$9.8M | -$7.9M | -$5.4M | -$9.4M |
| Net margin | −8.3% | −31.3% | −17.1% | −24.3% | −26.6% | −39.6% | −56.3% | −72.0% | −59.8% | −45.2% | −26.5% | −52.5% |
| Diluted EPS | $-0.05 | $-0.16 | $-0.10 | $-0.13 | $-0.15 | $-0.21 | $-0.34 | $-0.44 | $-0.33 | $-0.27 | $-0.18 | $-0.33 |
| EBITDA | -$772.0K | -$8.3M | -$4.3M | -$6.5M | -$7.2M | -$10.1M | -$11.0M | -$7.2M | -$8.0M | -$6.3M | -$3.9M | -$8.4M |
| Operating cash flow | -$1.0M | -$9.4M | $908.0K | -$785.0K | -$3.5M | -$17.0M | -$8.6M | -$5.4M | -$5.0M | -$12.0M | $2.1M | -$10.1M |
| Free cash flow | -$1.4M | -$9.6M | $692.0K | -$899.0K | -$3.8M | -$17.2M | -$8.7M | -$5.8M | -$5.6M | -$12.4M | $1.3M | -$10.7M |
| Diluted shares | 73.1M | 69.6M | 68.9M | 67.3M | 66.2M | 61.5M | 37.1M | 30.3M | 30.1M | 29.5M | 29.1M | 28.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $19.2M | $13.2M | $28.1M | $28.0M | $11.0M | $20.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $61.5M | $61.3M | $65.8M | $65.7M | $55.5M | $55.3M |
| Total assets | $131.5M | $125.4M | $141.6M | $145.5M | $134.7M | $142.0M |
| Total liabilities | $109.9M | $108.4M | $115.3M | $114.1M | $103.1M | $102.5M |
| Shareholders' equity | $21.6M | $17.1M | $26.2M | $31.4M | $31.5M | $39.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology